Manufacturer ‘panacea’ that Trump asks for cure with support from …


The American producer of Regeneron wants to widely distribute the antibody treatment that President Turmp received to fight the coronavirus and is requesting accelerated approval from the US authorities. For the time being, however, there is no scientific evidence that the treatment is effective against Covid-19.

The drug company Regeneron said Wednesday evening that it had filed with the Food and Drug Administration for urgent approval of the experimental antibody cocktail that President Trump had praised just hours earlier with no evidence that it works effectively as a “ cure ” for the coronavirus. Trump himself argued that such approval would only be a formality.

The company initially wants to help 50,000 patients. Far less than the “hundreds of thousands” of doses Trump promised in a video released Wednesday.

In that five-minute video, Trump said it was a “blessing from God” that he was infected with the coronavirus and that the Regeneron cocktail had suddenly made him better. “I felt incredible,” he said. “I immediately felt good.”

However, there is not enough evidence that the treatment is what made him feel better, and his doctors have said he has taken other medications as well. Three in all. Trump, it now appears, was given a tough antibody cocktail. And then a strong antiviral and steroids.

READ ALSO. Trump promises Americans will receive the same treatment as him for free: “My infection was a blessing from God”

“Initial results look promising,” said Regeneron in a press release. “The cocktail reduced virus levels, especially in people who don’t produce antibodies themselves. But the company has not yet released detailed data to back up its claim. Clinical studies have not yet been completed.

Not available that quickly

The company said it expects to have doses available for 300,000 patients in the coming months. Under the agreement with the federal government, those doses would be made available free of charge.

But scientists in the US want to see first test results before they consider the drug as a medicine for corona.

Toxicologist Jan Tytgat (KU Leuven) also says that the drug has not been part of broad-scale studies so far. In addition, he says, it seems impossible to produce the drug on a large scale quickly, as President Trump pointed out.

Source link by

*The article has been translated based on the content of Source link by
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!


Please enter your comment!
Please enter your name here